Card R T
Canadian Red Cross Blood Transfusion Service, Saskatoon Centre, Saskatchewan, Canada.
Transfus Med Rev. 1988 Mar;2(1):40-7. doi: 10.1016/s0887-7963(88)70030-9.
A great deal is known about the red cell membrane and its abnormalities in various pathologic states. During red cell storage there is a progressive development of spheroechniocytosis with eventual production of irreversibly nondeformable red cells. The loss of membrane function is most likely related to some abnormality in maintenance of the cytoskeleton of the red cell. These changes appear to occur independent of ATP levels. Despite the increasing knowledge of the structure and function of the red cell membrane very little as yet is known about the specific abnormality in the red cell membrane that occurs during storage in the blood bank. Recent evidence for abnormal spectrin-actin interaction and abnormal spectrin oxidation has been the most promising. Areas of interest for research include studies of the specific mechanisms by which the plasticizer DEHP interacts with the membrane, specific definition of the molecular defect in membrane proteins that occurs during storage, and means to prevent these. If such deterioration and membrane stiffening could be prevented then the quality of the red cells that are transfused would be improved both in their function and ability to survive in the microcirculation. A final need, while not of specific value to the red cell itself, is the development of media and additives that will allow for increased plasma and Factor VIII yields, one of the driving forces in the blood transfusion system.
关于红细胞膜及其在各种病理状态下的异常情况,我们已经了解很多。在红细胞储存过程中,球形红细胞增多症会逐渐发展,最终产生不可逆的不可变形红细胞。膜功能的丧失很可能与红细胞细胞骨架维持方面的某些异常有关。这些变化似乎独立于ATP水平而发生。尽管对红细胞膜的结构和功能的了解日益增加,但对于血库储存期间红细胞膜发生的具体异常情况,我们所知甚少。最近关于血影蛋白-肌动蛋白相互作用异常和血影蛋白氧化异常的证据最具前景。研究的感兴趣领域包括增塑剂邻苯二甲酸二(2-乙基己基)酯与膜相互作用的具体机制研究、储存期间膜蛋白分子缺陷的具体定义以及预防这些缺陷的方法。如果能够防止这种恶化和膜硬化,那么输注的红细胞在功能和在微循环中存活的能力方面都会得到改善。最后一个需求虽然对红细胞本身没有特定价值,但却是开发能够提高血浆和凝血因子VIII产量的培养基和添加剂,这是输血系统的驱动力之一。